Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel NaV1.7 produce distinct pain disorders by Cheng, Xiaoyang et al.
MOLECULAR PAIN
Cheng et al. Molecular Pain 2010, 6:24
http://www.molecularpain.com/content/6/1/24
Open Access RESEARCH
BioMed  Central
© 2010 Cheng et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research Mutations at opposite ends of the DIII/S4-S5 linker 
of sodium channel NaV1.7 produce distinct pain 
disorders
Xiaoyang Cheng1,2, Sulayman D Dib-Hajj1,2, Lynda Tyrrell1,2, Dowain A Wright3, Tanya Z Fischer1,2 and 
Stephen G Waxman*1,2
Abstract
Background: Two groups of gain-of-function mutations in sodium channel NaV1.7, which are expressed in dorsal root 
ganglion (DRG) neurons, produce two clinically-distinct pain syndromes - inherited erythromelalgia (IEM) and 
paroxysmal extreme pain disorder (PEPD). IEM is characterized by intermittent burning pain and skin redness in the feet 
or hands, triggered by warmth or mild exercise, while PEPD is characterized by episodes of rectal, ocular and 
mandibular pain accompanied with skin flushing, triggered by bowel movement and perianal stimulation. Most of the 
IEM mutations are located within channel domains I and II, while most of the PEPD mutations are located within 
domains III and IV. The structural dichotomy parallels the biophysical effects of the two types of mutations, with IEM 
mutations shifting voltage-dependence of NaV1.7 activation in a hyperpolarized direction, and PEPD mutations shifting 
fast-inactivation of NaV1.7 in a depolarized direction. While four IEM and four PEPD mutations are located within 
cytoplasmic linkers joining segments 4 and 5 (S4-S5 linkers) in the different domains (IEM: domains I and II; PEPD: 
domains III and IV), no S4-S5 linker has been reported to house both IEM and PEPD mutations thus far.
Results: We have identified a new IEM mutation P1308L within the C-terminus of the DIII/S4-S5 linker of NaV1.7, ten 
amino acids from a known PEPD mutation V1298F which is located within the N-terminus of this linker. We used 
voltage-clamp to compare the biophysical properties of the two mutant channels and current-clamp to study their 
effects on DRG neuron excitability. We confirm that P1308L and V1298F behave as prototypical IEM and PEPD 
mutations, respectively. We also show that DRG neurons expressing either P1308L or V1298F become hyperexcitable, 
compared to DRG neurons expressing wild-type channels.
Conclusions: Our results provide evidence for differential roles of the DIII/S4-S5 linker N- and C-termini in channel 
inactivation and activation, and demonstrate the cellular basis for pain in patients carrying these mutations.
Background
Gain-of-function mutations of voltage-gated sodium
channel NaV1.7 have been linked to two familial pain dis-
orders: inherited erythromelalgia (IEM) and paroxysmal
extreme pain disorder (PEPD) [1,2], which have distinct
clinical characteristics. IEM is characterized by intermit-
tent burning pain and skin redness in the distal extremi-
t i e s ,  t r i g g e r e d  b y  w a r m t h  o r  m i l d  e x e r c i s e  [ 1 , 3 ] .  I n
contrast, PEPD is characterized by episodes of rectal,
ocular and mandibular pain accompanied by skin flush-
ing, triggered by bowel movement and perianal stimula-
tion [4]. IEM is usually unresponsive to
pharmacotherapy, while PEPD pain is often relieved by
carbamazepine [2,4-6].
NaV1.7 is preferentially expressed in dorsal root gan-
glion (DRG) neurons and sympathetic ganglion neurons,
for example superior cervical ganglia [7-9], and produces
tetrodotoxin (TTX)-sensitive and fast-inactivating
inward currents [8,10]. NaV1.7 channels respond to small,
slow depolarizations by producing ramp currents which
could boost weak stimuli to reach threshold for action
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potentials [11]. Thus, NaV1.7 channels contribute to set-
ting action potential threshold in DRG neurons [12].
All but one of the known IEM mutations are localized
to domains I and II of the Nav1.7 channel, while all but
one of the known PEPD mutations are localized to
domains III and IV [13]. All IEM mutations studied thus
far produce a hyperpolarizing shift of activation of
NaV1.7 [14-24]. In contrast, all PEPD mutations studied
thus far impair channel fast-inactivation [2,5,6,25].
Intriguingly, the clustered distribution of the IEM and
PEPD mutants along the channel's polypeptide parallels
the effects on channel gating. Both IEM and PEPD muta-
tions increase excitability of DRG neurons [5,6,18,24,26],
providing a cellular basis for pain symptoms in patients
with these pain disorders.
Here, we report a new IEM mutation in NaV1.7
(P1308L) within the C-terminus of the S4-S5 linker of
domain III (DIII/S4-S5). P1308L is 9-10 amino acids dis-
tal to three PEPD mutations (V1298F, V1299D, and
V1299F), which are located within the N-terminus of
DIII/S4-S5. To better understand how these mutations
within the same part of the channel cause distinct pain
symptoms, we compared electrophysiological properties
of P1308L (IEM) and V1298F (PEPD) mutant channels
using voltage- and current-clamp recordings. We show
that these two mutations, both within the DIII/S4-S5
linker of the channel, have differential effects on activa-
tion and inactivation, and demonstrate that both increase
the excitability of DRG neurons.
Results
Clinical phenotype and identification of the P1308L 
mutation in Exon 21
The proband is a Hispanic male of Puerto Rican origin
who presented with a history of episodes of burning pain
in both feet, beginning around the age of 2 years. The
patient reported that warmth triggers pain and that cool-
ing provides relief, and prefers wearing open toed shoes
without socks, even during the winter months. Pharma-
cotherapy has not relieved these symptoms. Three of the
proband's children display similar symptoms of pain in
the feet, evoked by warmth, with early age of onset (Fig-
ure 1A). Similar to the proband, the children's pain is
ameliorated by cooling their feet, and they do not tolerate
wearing socks or shoes.
Sequence analysis of SCN9A  amplicons identified a
nucleotide change ca.3971C>T in Exon 21, which leads to
a substitution of proline 1308 of the reference NaV1.7
sequence [8] by leucine (P1308L). This mutation segre-
gates with the affected members in this family but not
with unaffected family members (Figure 1A) and was not
present in 100 control alleles. P1308 is located within the
C-terminus of the S4-S5 linker of domain III in NaV1.7
(DIII/S4-S5), and is highly conserved among all human
sodium channels (Figure 1B).
Three PEPD mutations (V1298F, V1298D, and V1299F)
have been reported within the N-terminus of the same
DIII/S4-S5 linker, 9-10 amino acids upstream from P1308
[2]. V1298 is also highly conserved among all human
sodium channels (Figure 1B).
Figure 1 Identification of the P1308L substitution in NaV1.7 in a 
family with IEM. A, The family pedigree of the proband carrying 
P1308L mutation. Circles denote females; squares denote males. The 
proband is indicated by an arrow. Blue symbols indicate subjects af-
fected with IEM. A (+) symbol denotes subjects heterozygous for the 
P1308L mutation in exon 21 and a (-) symbol denotes subjects without 
the mutation. B, Schematic of the topology of sodium channel and se-
quence alignment of DIII/S4-S5 linker of human sodium channels. The 
location of P1308L is indicated with blue symbol (filled blue circle), and 
sites of V1298F and V1299F are indicated with green and magenta 
symbols (filled green circle and filled pink circle), respectively. Se-
quence alignment revealed that both P1308 and V1298 are highly con-
served among human voltage-gated sodium channels.Cheng et al. Molecular Pain 2010, 6:24
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Voltage-clamp electrophysiology
The electrophysiological properties of wild-type (WT) or
mutant NaV1.7R channels were investigated using whole-
cell voltage-clamp recording in HEK293 cells stably
expressing WT, P1308L (IEM), or V1298F (PEPD) chan-
nels. Figure 2A shows representative inward Na+ currents
recorded from cells stably expressing WT, P1308L, or
V1298F NaV1.7R channels. Pilot experiments showed that
cells expressing mutant channels produced smaller cur-
rents than cells expressing WT channels. To determine
whether the reduced P1308L current density is the result
of intrinsic effects of the mutations or the effect of the site
of integration of the channel within the HEK 293 genome,
we measured the sodium current density in transiently
transfected HEK 293 cells. V1298F has previously been
reported [25] to produce smaller currents than WT chan-
nels in transiently transfected HEK 293 cells, and we did
not follow up on it in this study. The current density of
P1308L in transiently-transfected HEK 293 cells is signif-
icantly smaller than that of WT channels (WT: 285 ± 46
pA/pF, n = 9; P1308L: 90 ± 14, n = 11, p = 0.003, two-
tailed student's t test). To examine whether the smaller
current densities of mutant channels P1308L and V1298F
were due to lower protein expression, we used Western
blot to assay channel protein levels in transiently trans-
fected HEK 293 cells. When compared with WT channels
(set as 100%), the protein levels of mutant channels were
85 ± 12% (n = 3, p = 0.526) for P1308L and 123 ± 15% (n =
2, p = 0.352) for V1298F channels (Figure 2B), suggesting
that the smaller currents from mutant channels are not
caused by reduced channel synthesis in HEK 293 cells.
To minimize the difference of voltage error between
WT and mutant P1308L currents, HEK 293 cells produc-
ing currents larger than 10 nA (i.e. representing ≥ 4X the
Figure 2 P1308L and V1298F exhibit different effects on voltage-dependence of activation and fast inactivation. A, Representative families 
of traces of Na+ currents (INa) from voltage-clamped HEK293 cells stably expressing wild-type (WT), P1308L, or V1298F NaV1.7R channels. Cells were held 
at -100 mV, and Na+ currents were elicited by step depolarizations from -80 to +60 mV in 5 mV increments every 5 seconds. B. Western blot analysis 
of NaV1.7R WT and mutant channels in transfected HEK 293 cells. The loading variation was eliminated by normalizing the intensities of sodium chan-
nels with the intensities of β-actin of corresponding lanes. No statistic difference was observed between WT and mutant channels. C, Normalized peak 
current-voltage relationship for WT (n = 29), P1308L (n = 25), and V1298F (n = 26) NaV1.7R channels. D, Comparison of the voltage-dependent activa-
tion and steady-state fast inactivation of WT, P1308L, and V1298F channels. A hyperpolarizing shift (-9.6 mV) of activation was observed in the P1308L 
mutant channel, while the V1298F mutant channel showed a depolarizing shift (+16.1 mV) of steady-state fast-inactivation. E, Activation kinetics (mea-
sured as time-to-peak) of P1308L (n = 25) were faster at -20 mV and -15 mV, compared to WT channels (n = 29), whereas V1298F channels (n = 26) 
showed slower activation kinetics from -20 to +40 mV. F, Open-state fast-inactivation kinetics were measured by single-exponential fitting of the de-
cay phases of INa as shown in (A). When compared with wild-type channels (n = 25), V1298F mutant channels (n = 26) significantly slowed the inacti-
vation kinetics from -25 to +40 mV, whereas P1308L mutation (n = 19) showed faster inactivation kinetics at -30 and -25 mV.Cheng et al. Molecular Pain 2010, 6:24
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mean peak currents of P1308L channels) were excluded
from the analysis; none of the cells expressing P1308L or
V1298F channels produced sodium currents larger than
10 nA. Despite the exclusion of cells producing large WT
currents, the current densities of mutant channels were
still significantly smaller than that of WT channels (WT:
351 ± 25 pA/pF, n = 29; P1308L: 146 ± 15 pA/pF, n = 25, p
< 0.001 vs WT; V1298F: 183 ± 16 pA/pF, n = 26, p < 0.001
vs WT; non-parametric Kruskal-Wallis statistical test).
Like all IEM mutant channels characterized thus far,
P1308L mutation caused a hyperpolarizing shift (-9.6
mV) of activation (WT: V1/2,act = -21.8 ± 0.7 mV, k = 6.95 ±
0.11, n = 29; P1308L: V1/2,act = -31.4 ± 0.5 mV, k = 7.33 ±
0.09, n = 25; p < 0.001 for V1/2,act and p = 0.012 for k)
whereas V1298F, the PEPD mutation, had no effect on
activation (V1/2,act = -22.5 ± 0.7 mV, p = 0.680, and k = 6.83
± 0.07, p = 0.754, n = 26) (Figure 2C and 2D, Table 1).
P1308L mutation did not affect the midpoint (V1/2,fast) of
steady-state fast-inactivation, but altered the slope of
fast-inactivation curve (WT: V1/2,fast = -80.6 ± 1.1 mV, k =
6.32 ± 0.14, n = 13; P1308L: V1/2,fast = -78.9 ± 0.7 mV, p =
0.422, k = 5.65 ± 0.11, p = 0.002) (Figure 2D, Table 1). Like
other PEPD mutations characterized to date, V1298F
channels showed a depolarizing shift (+16.1 mV) of
steady-state fast-inactivation and a steeper inactivation
curve (V1/2,fast = -64.5 ± 0.9 mV, p < 0.001, k = 5.45 ± 0.15,
p < 0.001, n = 13) (Figure 2D, Table 1).
Activation kinetics (measured as time-to-peak) of
P1308L channels were faster at -20 and -15 mV, whereas
V1298F mutant channels were slower (between -20 to
+40 mV) compared to WT channels (Figure 2E). The
kinetics of open-state fast-inactivation were analyzed by
mono-exponential fit of the decaying phase of Na+ cur-
rents in Figure 2A. V1298F mutant channels exhibited
slower inactivation kinetics, compared to WT, from -25
to +40 mV, whereas P1308L channels showed faster
kinetics at -30 and -25 mV (Figure 2F). The faster inacti-
vation kinetics of P1308L may be due to enhanced activa-
tion of P1308L channels, since open-state fast-
inactivation is coupled to the activation state of channels
[27].
Deactivation kinetics reflect the transition of channels
from the open state to the closed state. As with most IEM
mutations, P1308L mutant channels showed slow deacti-
vation of Na+ currents at all potentials tested, indicating
that the mutant channel resides longer in the open state,
whereas V1298F mutation had no effect on deactivation
kinetics (Figure 3A).
Steady-state slow-inactivation develops over a long
time frame (from seconds to minutes) upon sustained
stimulation. The slow-inactivation of sodium channels
was evaluated using 30-s prepulses at potentials ranging
from -130 to +10 mV. P1308L did not significantly affect
the voltage-dependence of slow-inactivation of mutant
channels (WT: V1/2,slow = -63.8 ± 1.7 mV, n = 14; P1308L:
V1/2,slow = -68.4 ± 1.2 mV, n = 10; p = 0.072, Table 2, Figure
3B), while V1298F depolarized the slow-inactivation
curve of mutant channels by +6 mV (V1298F: V1/2,slow = -
57.8 ± 1.1 mV, n = 12; p = 0.011, Table 2, Figure 3B). Both
mutant channels decreased the slope factor of the inacti-
vation curve, and increased the fraction of channels resis-
tant to slow inactivation (Rresist, expressed as % of
maximal current and calculated as offset (A) × 100%. For
WT: k = 12.6 ± 0.3, Rresist = 14.0 ± 1.2%, n = 14; P1308L: k
= 10.5 ± 0.3, p < 0.001, Rresist = 19.1 ± 1.4%, n = 10, p =
0.03; V1298F: k = 9.2 ± 0.3, p < 0.001, Rresist = 25.6 ± 1.5%,
n = 12, p < 0.001) (Table 2, Figure 3B).
Repriming kinetics reflect the recovery rate of channels
from fast-inactivation state, and in the case of NaV1.7,
repriming kinetics may regulate how fast a neuron can
repetitively fire [28]. The P1308L mutation had no signif-
icant effect on recovery fractions or on repriming kinetics
at tested potentials (Figure 4A, B, C, and 4D). In contrast,
V1298F mutant channels showed faster repriming kinet-
ics at all tested potentials (Figure 4D) and higher recovery
fraction at recovery potentials from -90 to -60 mV (Figure
4A, B and 4C). The larger recovered fraction of V1298F
channels is related to the depolarizing shift of fast-inacti-
vation, which increases the proportion of channels avail-
able for activation at these recovery potentials. Faster
repriming kinetics and larger recovery fraction of V1298F
channels are expected to endow neurons housing this
Table 1: Parameters of voltage-dependent activation and steady-state fast-inactivation of WT, P1308L, and V1298F NaV 
1.7R channels.
Activation Steady-state fast inactivation
V1/2, act k n V1/2, fast k n
WT -21.8 ± 0.7 6.95 ± 0.11 29 -80.6 ± 1.1 6.32 ± 0.13 14
P1308L -31.4 ± 0.5* 7.33 ± 0.09* 25 -78.9 ± 0.7 5.65 ± 0.11* 13
V1298F -22.5 ± 0.7 6.83 ± 0.07 26 -64.5 ± 0.9* 5.45 ± 0.15* 13
* p < 0.05 P1308L or V1298F channels vs WT NaV1.7R channels.Cheng et al. Molecular Pain 2010, 6:24
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mutation with the ability to fire at higher frequency com-
pared to wild type channels.
NaV1.7 channels activate in response to small, slow
depolarization, which allows them to amplify weak stim-
uli, e.g. generator potentials, bringing the membrane
potential closer to the threshold for initiation of action
potentials [11]. Therefore, we examined the effects of
mutations on the channel response to slow ramp depolar-
ization (600 ms ramp depolarization from -100 mV to
+20 mV; 0.2 mV/ms). Figure 5A shows representative
ramp currents recorded from cells expressing WT,
P1308L and V1298F channels. The ramp currents, mea-
sured as percentage of peak current, generated by P1308L
channels were about 4X larger than those of WT chan-
nels (WT: Iramp = 0.26 ± 0.03%, n = 12; P1308L: Iramp =
1.09 ± 0.11%, n = 15, p < 0.001) (Figure 5B). Consistent
with the hyperpolarized shift of voltage-dependence of
activation, P1308L mutation also shifted the peak of the
ramp currents to more negative potentials (WT: Vramp = -
44.8 ± 1.4 mV, n = 12; P1308L: Vramp = -51.1 ± 0.9 mV, n =
15, p < 0.001) (Figure 5C). Compared to WT channels,
V1298F channels also produced 2X larger ramp currents,
but had no effect on the voltage for peak ramp currents
(V1298F: Iramp = 0.58 ± 0.06%, n = 16, p = 0.015; Vramp = -
42.5 ± 0.8 mV, n = 16, p = 0.280) (Figure 5B, C).
Current-clamp electrophysiology
To examine the effects of the P1308L and V1298F muta-
tions on DRG neuron excitability, current-clamp record-
ings were performed on neonatal rat DRG neurons
transfected with WT, P1308L, or V1298F constructs
combined with GFP. The input resistance (Rinput), resting
Figure 3 The P1308L and V1298F mutations have different effects on channel deactivation and slow-inactivation. A, To measure deactivation 
kinetics, cells were held at -100 mV and tail currents were generated by a brief 0.5-ms depolarization to -20 mV followed by a series of repolarizations 
ranging from -100 to -40 mV to elicit tail currents. P1308L mutant channels (n = 11) showed slower deactivation kinetics than WT channels (n = 15) at 
all tested potentials, whereas V1298F had no effect on deactivation kinetics (n = 15). B, Steady-state slow-inactivation was examined by a series of 
prepulses (30 s) from -130 to +10 mV followed by 100-ms return pulse to -120 mV, then a 20-ms test pulse to -10 mV. The V1298F mutation shifted 
the slow-inactivation curve to more positive potential, whereas the P1308L mutation had no effect on V1/2,slow, slow. Both mutations increased the 
fraction of channels resistant to slow-inactivation (Rresist).
Table 2: Parameters of steady-state slow-inactivation of WT, P1308L, and V1298F NaV1.7R channels.
Steady-state slow inactivation
V1/2, slow k Rresist(%) n
WT -63.8 ± 1.7 12.6 ± 0.3 14.0 ± 1.2 14
P1308L -68.4 ± 1.2 10.5 ± 0.3* 19.1 ± 1.4* 10
V1298F -57.8 ± 1.1* 9.2 ± 0.3* 25.6 ± 1.5* 12
* p < 0.05 P1308L or V1298F channels vs WT NaV1.7R channels.Cheng et al. Molecular Pain 2010, 6:24
http://www.molecularpain.com/content/6/1/24
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membrane potential (RMP), current threshold of action
potential, and firing frequency in small DRG neurons
were examined. Expression of mutant channels did not
change Rinput and RMP of DRG neurons (Table 3). How-
ever, expression of P1308L channels decreased the cur-
rent threshold of action potential in DRG neurons (WT:
188 ± 14 pA, n = 38; P1308L: 122 ± 10 pA, n = 50, p <
0.001, Table 3, Figure 6A), whereas the action potential
threshold of DRG neurons expressing V1298F channels
was not significantly different from that of neurons
expressing WT channels (V1298F: 154 ± 18, n = 27, p =
0.215, Table 3, Figure 6A).
Previous studies have shown that DRG neurons are able
to fire repetitively in response to sustained depolarizing
stimuli [29-31]. In this study, 11 out of 38 (29%) small
DRG neurons expressing WT NaV1.7R channels pro-
duced 3 or more action potentials, whereas a larger pro-
portion of neurons expressing mutant channels were able
to fire 3 or more spikes (64% for P1308L, and 78% for
V1298F). Figure 6B shows the mean firing frequency of
DRG neurons in response to a series of 1-s current injec-
Figure 4 The P1308L and V1298F mutations have different effects on repriming. Cells were held at -100 mV, and fast-inactivation was initiated 
by a 20-ms depolarization to 0 mV, followed by a recovery period (2-300 ms) at a recovery potential. The available channels were then measured with 
a 10-ms test pulse at 0 mV. Recovery fraction was calculated by normalizing the peak currents in response to test pulses, to peak currents of prepulses 
after various recovery durations (2-300 ms) at different recovery potentials, and plotted as a function of recovery potentials. A, B, and C, V1298F mu-
tant channels show higher recovery fractions than WT channels at recovery potentials from -90 to -70 mV, whereas P1308L channels do not affect 
recovery fraction. D, Repriming kinetics was calculated by mono-exponential fits of the recovery rate at different recovery duration. V1298F channels 
showed faster repriming kinetics than WT channels at all testing potentials, whereas P1308L had no effect on the repriming kinetics.Cheng et al. Molecular Pain 2010, 6:24
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tions ranging from 25 to 500 pA in 25 pA increments, and
Figure 6C shows the responses elicited after injecting cur-
rents approximately 1.5X and 2X the threshold from the
same neurons. Both P1308L and V1298F increased the
firing frequency in transfected DRG neurons.
Discussion
We have identified a new NaV1.7 mutation (P1308L)
which is only the second IEM mutation to be reported
outside domains I and II of NaV1.7. The P1308L muta-
tion, from a family with IEM displaying distal extremity
pain triggered by warmth, is located within the C-termi-
nus of the channel DIII/S4-S5 linker, and is separated by
only 9-10 amino acid residues from three PEPD muta-
tions - V1298F, V1298D, and V1299F - which are located
within the N-terminus of this linker. We show here that
despite their proximity within the same linker, the
P1308L and V1298F mutations have markedly different
effects on NaV1.7 channel gating properties. P1308L
hyperpolarizes activation and slows deactivation,
whereas V1298F depolarizes fast-inactivation and
enhances repriming. These data provide evidence for a
differential role of the N- and C-termini of the NaV1.7
DIII/S4-S5 linker in channel activation and fast-inactiva-
t i o n .  O u r  d a t a  a l s o  s h o w  t h a t  b o t h  m u t a n t s  p r o d u c e
larger ramp currents and increase DRG neuronal excit-
ability, which provides a cellular basis for pain in patients
carrying these IEM and PEPD mutations.
The DIII/S4-S5 linker sequence is highly conserved
among sodium channels (Figure 1), suggesting a con-
served role in channel function. Crystal structures of a
few ion channels, and predicted models of others, depict
a voltage-sensor connected to the pore (segments S5 and
S6) via the S4-S5 linker [32-37]. The S4-S5 linker poten-
tially interacts with the C-terminal part of S6 which is
bent around a glycine "hinge residue" [37], leading to the
opening of the channel gate, and proximity of the S4-S5
l i n k e r  t o  S 6  w i t h i n  e a c h  d o m a i n  h a s  b e e n  v e r i f i e d  i n
hERG channels by cysteine substitution [38]. Thus, muta-
tions in S4-S5 linkers are expected to affect activation,
consistent with the findings that mutations in these link-
ers of NaV1.7 induce significant hyperpolarizing shifts of
channel activation [[17,20,21], and this study].
Several mechanisms may underlie the effect of PEPD
mutations within the N-terminal part of the DIII/S4-S5
linker on NaV1.7 fast-inactivation: the contribution of
Figure 5 The P1308L and V1298F mutations enhance the response to slow ramp depolarization. HEK293 cells were held at -100 mV and a de-
polarizing voltage ramp from -100 mV to +20 mV was applied at a rate of 0.2 mV/ms. A, Representative ramp currents from WT (black), P1308L (red), 
and V1208F (grey) channels. Currents were normalized to maximal peak currents elicited by step depolarizations in Figure 1B. B, Both P1308L and 
V1298F mutations significantly increase the relative amplitude of ramp currents (WT: 0.26 ± 0.03%, n = 12; P1308L: 1.09 ± 0.11%, n = 15, p < 0.001 vs 
WT; V1298F: 0.58 ± 0.06%, n = 16, p = 0.015 vs WT). C, The potential of peak ramp currents was more negative in P1308L mutant channels than in WT 
and V1298F channels (WT: -44.8 ± 1.4 mV, n = 12; P1308L: -51.1 ± 0.9 mV, n = 15, p < 0.001 vs WT; V1298F: -42.5 ± 0.8 mV, n = 16, p = 0.280 vs WT).
Table 3: Current clamp properties of DRG neurons transfected with WT, P1308L, or V1298F NaV1.7R construct.
Construct n Rinput(MΩ) RMP (mV) Threshold (pA)
WT 38 605 ± 57 -55.9 ± 1.1 188 ± 14
P1308L 50 749 ± 70 -52.4 ± 1.1 122 ± 10*
V1298F 27 598 ± 46 -55.1 ± 1.5 154 ± 18
* p < 0.05 vs WT NaV1.7R channels.Cheng et al. Molecular Pain 2010, 6:24
http://www.molecularpain.com/content/6/1/24
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residues within DIII- and DIV/S4-S5 linkers to the dock-
ing receptor for the fast-inactivation IFMT tetrapeptide
[39-42], or predicted mutant-induced perturbation of the
α-helical structure of the DIII/S4-S5 linker [25], or this
linker potential interaction with the plasma membrane
[43]. It is possible that the V1298 contributes to the IFMT
docking site, and that V1298F substitution interferes with
stable docking of the inactivation particle, impairing fast-
inactivation of the mutant channel. There is no direct evi-
dence, however, that N-terminal residues of DIII/S4-S5
Figure 6 Excitability is increased in DRG neurons transfected with the P1308L or V1298F mutant channels. A, Responses of DRG neurons ex-
pressing WT, P1308L, or V1298F channels to a series of current stimuli with 5-pA increment. DRG neurons expressing P1308L channels showed a lower 
action potential threshold (P1308L: 122 ± 10 pA, n = 50, p < 0.001 vs WT: 188 ± 14 pA, n = 38), while expression of V1298F did not significantly change 
the action potential threshold (V1298F: 154 ± 18 pA, n = 27, p = 0.215 vs WT). B, The mean firing frequency of DRG neurons expressing WT, P1308L, or 
V1298F channels in response to a series of 1-s current injections ranging from 25 to 500 pA with 25-pA increments. Both P1308L and V1298F elevated 
firing frequency of transfected DRG neurons. * indicates p < 0.05 for P1308L vs WT channels, * indicates p < 0.05 for V1298F vs WT channels. C, Repre-
sentative traces showing responses to current stimuli approximately 1.5× (top) and 2× (bottom) action potential threshold, recorded from DRG neu-
rons expressing WT, P1308L, or V1298F channels from (A).Cheng et al. Molecular Pain 2010, 6:24
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linker, including V1298, participate in forming the IFMT
docking site. Related to an indirect effect on interaction
of the IFMT peptide with its docking receptor is the pos-
sible effect of V1298F on the putative interactions of the
DIII/S4-S5 linker with the plasma membrane. X-ray crys-
tallographic modeling structure of voltage-gated potas-
sium channel KV1.2 places the S4-S5 linker parallel to the
membrane inner surface, facing aqueous and lipid envi-
ronment on opposite sides [43]. By analogy, sodium chan-
nel S4-S5 linkers may assume a similar topology, with
V1298 in the DIII/S4-S5 facing the membrane lipid layer.
Thus the partial positive charges that are present on the
hydrogen atoms of aromatic residues [44] may perturb
this arrangement in the case of the NaV1.7/V1298F
mutant, destabilizing the receptor for the fast-inactiva-
tion gate and impairing NaV1.7 fast-inactivation. This
view is supported by the impairment of fast-inactivation
by another PEPD mutation V1298D in which a charge is
introduced at this position [2,25]. Alternatively, the
V1298F substitution may produce an allosteric effect that
alters the S4-S5 linker α-helical structure, destabilizing
IFMT-receptor interaction, thus impairing fast-inactiva-
tion [25].
The important roles of V1298 and P1308, located at
opposite ends of the DIII/S4-S5 linker, in regulating chan-
nel gating are further supported by identification of dis-
ease-causing mutations of corresponding residues in
other channels: NaV1.1/V1335M (corresponding to
NaV1.7/V1298), NaV1.4/P1158S (corresponding to
NaV1.7/P1308), and NaV1.5/P1332L (corresponding to
NaV1.7/P1308). NaV1.1/V1335M mutation in patients
with severe myoclonic epilepsy of infancy replaces the
hydrophobic valine residue with the polar methionine,
but the effects of this mutation on channel gating has not
been studied by patch-clamp [45]. Interestingly, NaV1.4/
P1158S and NaV1.5/P1332L produce hyperpolarizing
shift of activation as does NaV1.7/P1308L [46-48] and a
larger Rresist of slow-inactivation, but note that NaV1.4/
P1158S shows a depolarized shift of V1/2,slow; slow-inacti-
vation of NaV1.5/P1332L was not tested. However, unlike
NaV1.7/P1308L, NaV1.5/P1332L hyperpolarizes steady-
state fast-inactivation of the mutant channels [46]. Taken
together, these data suggest an important role for a pro-
line amino acid within the C-terminus of the DIII/S4-S5
linker in channel activation, although the effects of this
residue on inactivation states appear to be isoform-
dependent.
Expression of either P1308L or V1298F induced hyper-
excitability of DRG neurons, compared to neurons
expressing WT channels. P1308L reduced the current
threshold for single action potential (WT: 188 ± 14 pA;
P1308L: 122 ± 10 pA), consistent with the role of NaV1.7
as a threshold channel [11,12]. While V1298F increased
ramp currents, similar to the P1308L channels, it did not
cause a statistically-significant reduction in the threshold
for single action potentials (WT: 188 ± 14 pA; V1298F:
154 ± 18 pA). However, expression of either P1308L or
V1298F increased the number of DRG neurons that fired
≥ 3 spikes in response to a 1-s stimulus (Fig. 6). The abil-
i t y  o f  b o t h  t y p e s  o f  m u t a t i o n  t o  i n d u c e  D R G  n e u r o n
hyperexcitability is in agreement with our previous find-
ings of a similar effect of other IEM and PEPD mutations
[5,6,18,19,24,26], and provides a cellular basis for pain in
patients carrying these mutations.
In summary, the present study shows that the V1298F
(PEPD) and P1308L (IEM) mutations, both substituting
single amino acids within the DIII/S4-S5 linker of NaV1.7
channel, increase DRG neuronal excitability by affecting
different biophysical properties of NaV1.7. Our results
implicate the N- and C-termini of the DIII/S4-S5 linker in
different aspects of NaV1.7 channel gating, and demon-
strate that mutations at those sites differentially affect
channel properties.
Methods
Exon Screening
Patients were recruited under an approved institutional
protocol for research on human subjects. Human varia-
tion control DNA panel (25 white males, 25 white females
for a total of 100 alleles; Coriell Institute, Camden, NJ)
was the source of control samples. All coding exons and
flanking intronic sequences, were amplified and
sequenced as described previously [18]. Genomic
sequences were compared with the reference NaV1.7
cDNA [8] using the basic local alignment search tool
(BLAST; National Library of Medicine, Bethesda, MD)
and Lasergene (DNAStar, Madison, WI). Sequencing was
performed at the Howard Hughes Medical Institute/Keck
Biotechnology Center at Yale University (New Haven,
CT).
Plasmids
The TTX-R human NaV1.7R  expression plasmid con-
struct generated by Y362S substitution in the cDNA
insert described in Klugbauer et al [8] was described pre-
viously [28]. The V1298F and P1308L substitutions were
introduced into NaV1.7R  using QuickChange XL site-
directed mutagenesis (Stratagene, La Jolla, CA).
Western blot analysis
To examine the expression level of WT or mutant chan-
nels, HEK 293 cells were transiently transfected WT or
mutant construct together with human β1- and β2-sub-
units. After 24-hr incubation, cells were washed once
with PBS and lysated with sample buffer. Cell lysates wereCheng et al. Molecular Pain 2010, 6:24
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incubated at 37°C for 25 min followed by brief sonication
on ice. Supernatants (10 μl) of cell lysates were loaded on
a 4-12% Bis-Tris Gel (Invitrogen) for electrophoresis and
transferred onto a Nitrocellulose membrane (30 V for 2
hr). The membrane was blocked with 10% dry milk in
TBS-tween (0.1%) overnight at 4°C. After washing, the
membrane was cut in half and each half (upper, wells
side) and lower (bottom side) were incubated with appro-
priate primary (room temperature for 2 hr) and second-
ary antibodies (room temperature for 1 hr). The primary
antibody for the upper portion of the membrane was
mouse anti-pan sodium channel (Sigma; 1:1000), and for
the lower half was the rabbit anti-β-actin (Abcam;
1:5000). The secondary antibodies were polyclonal goat
anti-mouse HRP (1:10,000) and goat anti-rabbit HRP
(1:10,000), respectively. The blots were washed six times
with TBS-tween 20 buffer. The luminescence was
induced by Western Lightning Chemiluminescent
Reagent (Perkin Elmer Life Sciences, Boston, MA) and
detected by film exposure (BioMax XAR, Kodak, Roches-
ter, NY). Band intensities were measured using KODAK
MI™ software. The intensities of WT, P1308L, V1298F
channels were normalized with the intensities of β-actin
of the corresponding lanes to eliminate sample loading
variability. The normalized intensity of WT channels was
set as 100%, and the level of mutant channels was
e x p r e s s e d  a s  t h e  p e r c e n t a g e  o f  t h a t  o f  W T  c h a n n e l s .
Non-transfected HEK 293 cells were used as negative
control for antibody specificity.
Voltage-clamp recordings
Whole-cell voltage-clamp recordings of HEK293 cells
expressing wild type (WT), V1298F, or P1308L mutant
NaV1.7R channels were obtained with an Axopatch 200B
amplifier (Axon Instruments, Foster City, CA). All exper-
iments were conducted at room temperature (20-22°C).
Fire-polished electrodes (0.6-1.3 MΩ) were fabricated
from 1.6 mm outer diameter borosilicate glass micropi-
pettes (World Precision Instruments, Sarasota, FL). The
pipette potential was adjusted to zero before seal forma-
tion, and liquid junction potential was not corrected.
Capacity transients were cancelled and voltage errors
were minimized with 80-90% series resistance compensa-
tion. Currents were acquired with Clampex 9.2, 6 min
after establishing whole-cell configuration, sampled at a
rate of 50 or 100 kHz, and filtered at 5 kHz.
For characterizing channel biophysical properties,
HEK293 cells stably expressing either WT or mutant
(V1298F or P1308L) NaV1.7R channels were generated as
described previously [21]. For current-voltage relation-
ships, cells were held at -100 mV and stepped to a range
of potentials (-80 to +60 mV in 5 mV increments) for 100
ms. Peak inward currents (I) were plotted as a function of
depolarization potential to generate I-V curves. Activa-
tion curves were obtained by converting I to conductance
(G) at each voltage (V) using the equation G = I/(V-Vrev),
where Vrev is the reversal potential that was determined
for each cell individually. Activation curves were then fit
with Boltzmann functions in the form of G  =  Gmax/
{1+exp [(V1/2, act-V)/k]}, where Gmax  is the maximal
sodium conductance, V1/2,act is the potential at which
activation is half-maximal, V is the test potential, and k is
the slope factor.
Steady-state fast-inactivation was achieved with a series
of 500 ms prepulses (-140 to -10 mV in 10 mV incre-
ments) and the remaining non-inactivated channels were
activated by a 40 ms step depolarization to -10 mV.
Steady-state slow-inactivation was determined with 30 s
prepulses at voltages ranging from -130 to +10 mV fol-
lowed by a 100 ms hyperpolarization at -120 mV to
remove fast-inactivation. Remaining available channels
were activated by a 20 ms test pulse to -10 mV. Peak
inward currents obtained from steady-state fast-inactiva-
tion and slow-inactivation protocols were normalized
with the maximal peak current (Imax) and fit with Boltz-
man functions:
where A represents the offset, V represents the inacti-
vating prepulse potential, and V1/2 represents the mid-
point of the inactivation curve. In the text, V1/2,fastand V1/
2,slow were used to represent the midpoints for steady-
state fast-inactivation and slow-inactivation, respectively.
Deactivation was examined using a short (0.5 ms)
depolarizing pulse to -20 mV followed by a 50 ms repolar-
izing pulse to potentials ranging from -100 to -40 mV in 5
mV increments. Deactivation kinetics were calculated by
fitting the decaying currents with a single exponential
function. Ramp currents were elicited with a slow depo-
larizing voltage ramp from -100 to +20 mV at a rate of 0.2
mV/ms. The absolute ramp current amplitude was nor-
malized to the maximal peak current obtained by the I-V
protocol.
The recovery of NaV1.7R channels from fast-inactiva-
tion (repriming) was examined using a two-pulse proto-
col with the interpulse intervals varying from 2 ms to 300
ms. Repriming was studied at four recovery potentials (-
100, -90, -80, and -70 mV) for all three channels, and
V1298F was also tested at an additional recovery poten-
tial of -60 mV. Recovery rates were measured by normal-
izing the peak current elicited by the test pulse with that
of prepulse at 0 mV after various recovery durations (2-
300 ms) at different recovery potentials, and plotted as a
function of recovery potentials. Recovery time constants
II A A e x p V V k max /( ) / { [ ( ) / ] } , / =+− + − 11 12Cheng et al. Molecular Pain 2010, 6:24
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were calculated using mono-exponential fits of the recov-
ery rates at different recovery duration.
The pipette solution contained (in mM): 140 CsF, 10
NaCl, 1 EGTA, 10 dextrose, and 10 HEPES, pH 7.32
(adjusted with CsOH), and the osmolarity was adjusted to
308 mOsmol/L with sucrose. The extracellular bath solu-
tion for voltage-clamp contained (in mM): 140 NaCl, 3
KCl, 1 MgCl2, 1 CaCl2, 10 dextrose, 10 HEPES, pH 7.35
(adjusted with NaOH), and the osmolarity was adjusted
to 315 mOsmol/L with sucrose. Tetrodotoxin (TTX, 300
nM) was added to the bath solution to block endogenous
voltage-gated sodium currents in HEK293 cells, permit-
ting currents from WT or V1298F or P1308L mutant
NaV1.7R channels to be recorded in isolation.
Isolation and transfection of DRG neurons; current-clamp 
recordings
DRG neurons were isolated from 1- to 4-day-old Sprague
Dawley rats as described previously [49]. WT or mutant
NaV1.7R channels were electroporated into DRG neurons
together with GFP constructs (channel:GFP ratio of 5:1)
using Rat Neuron Nucleofector Solution (Lonza, Walk-
ersville, MD) as described previously [49]. Small (20-25
μm) DRG neurons with robust green fluorescence were
selected for current-clamp recording 18-48 hr post trans-
fection. Whole-cell configuration was obtained in volt-
age-clamp mode before starting current-clamp recording.
Input resistance was determined as the slope of the linear
fit of the hyperpolarizing responses to a series of current
steps from 5 to 40 pA in 5 pA increments. Current
threshold for action potential generation was determined
by a series of depolarizing currents in 5 pA increments.
Repetitive firing frequency was examined in response to a
series of 1-s current steps from 25 to 500 pA in 25 pA
increments.
The pipette solution for current-clamp recording con-
tained (in mM): 140 KCl, 0.5 EGTA, 3 Mg-ATP, and 5
HEPES, pH 7.3 (adjusted with KOH), and the osmolarity
was adjusted to 308 mOsmol/L with sucrose. The extra-
cellular bath solution for current-clamp recording con-
tained (in mM): 140 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 10
dextrose, 10 HEPES, pH 7.3 (adjusted with NaOH), and
the osmolarity was adjusted to 315 mOsmol/L with
sucrose.
Data analysis
Data were analyzed using Clampfit 9.2 (Molecular
Devices) and OriginPro 8 (Microcal Software,
Northampton, MA), and presented as means ± SE. Unless
otherwise noted, we used one-way ANOVA followed by
Tukey post hoc test for multi-group analysis for statistical
significance. For comparison of firing frequency between
neurons transfected with WT and mutant channels was
performed with Mann-Whitney test. We report exact p
values except when they were smaller than 0.001, which
were reported as p < 0.001.
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